Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.
about
What makes gouty inflammation so variable?Hydrogen sulfide inhibits the NLRP3 inflammasome and reduces cytokine production both in vitro and in a mouse model of inflammation.Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation.Phloxine O, a Cosmetic Colorant, Suppresses the Expression of Thymic Stromal Lymphopoietin and Acute Dermatitis Symptoms in Mice.Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome.Disease-Associated Particulates and Joint Inflammation; Mechanistic Insights and Potential Therapeutic Targets.
P2860
Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting ASC in NLRP3 inflamm ...... strategy to treat acute gout.
@en
Targeting ASC in NLRP3 inflamm ...... strategy to treat acute gout.
@nl
type
label
Targeting ASC in NLRP3 inflamm ...... strategy to treat acute gout.
@en
Targeting ASC in NLRP3 inflamm ...... strategy to treat acute gout.
@nl
prefLabel
Targeting ASC in NLRP3 inflamm ...... strategy to treat acute gout.
@en
Targeting ASC in NLRP3 inflamm ...... strategy to treat acute gout.
@nl
P2093
P2860
P356
P1433
P1476
Targeting ASC in NLRP3 inflamm ...... strategy to treat acute gout.
@en
P2093
Gabsik Yang
Hye Eun Lee
Hyun Ho Park
Jae Young Choi
Joo Young Lee
Nam Doo Kim
Seongkeun Jeong
Yunjin Jung
P2860
P2888
P356
10.1038/SREP38622
P407
P577
2016-12-09T00:00:00Z